Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autosomal Dominant Polycystic Kidney: early-phase trial registry
2 of 7 indexed Autosomal Dominant Polycystic Kidney trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Autosomal Dominant Polycystic Kidney: 7 US clinical trials tracked, 2 recruiting.
Autosomal Dominant Polycystic Kidney is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 4 of these trials.
Enrollment posture brief
Registry condition autosomal-dominant-polycystic-kidney
OPEN 2 | RECR 29% | LATE 1 | EARLY 2 | RANK #2497 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Autosomal Dominant Polycystic Kidney lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autosomal Dominant Polycystic Kidney on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autosomal Dominant Polycystic Kidney is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Autosomal Dominant Polycystic Kidney research.
University of Colorado, Denver accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Autosomal Dominant Polycystic Kidney enrolment sits around 103 participants.
Median target enrolment is 103 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Autosomal Dominant Polycystic Kidney research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
University of Colorado, Denver
NCT06582875
A Prospective Observational Study of Foam Sclerotherapy .
Mayo Clinic
NCT04111692
Statin Therapy in Patients With Early Stage ADPKD
University of Colorado, Denver
NCT03273413
Daily Caloric Restriction in ADPKD
University of Colorado, Denver
NCT04907799
Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD
University of Colorado, Denver
NCT06496542
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
Biogen
NCT03366337
A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease
The Rogosin Institute
NCT03102632
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Autosomal Dominant Polycystic Kidney records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autosomal Dominant Polycystic Kidney trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autosomal Dominant Polycystic Kidney page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Autosomal Dominant Polycystic Kidney trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Colorado, Denver sponsors the most Autosomal Dominant Polycystic Kidney trials on record, review their full trial history before evaluating a specific study. See University of Colorado, Denver's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autosomal Dominant Polycystic Kidney condition card totals 7 registered trials; most-linked intervention Standard advice control; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.